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While the psychological and health benefits of knowing one’s HIV diagnosis have been 
documented for adults and adolescents, practice is still in development for younger 
children. Moderating conditions for whether or not to tell a child he/she has HIV vary by 
region and local context. They include accessibility of treatment, consideration of HIV as 
a stigmatizing condition, prevalence of HIV, and an accompanying presumption that any 
illness is HIV-related, parent or caregiver concerns about child reactions, child’s worsening 
health, assumptions about childhood and child readiness to know a diagnosis, and lack 
of policies such as those that would prevent bullying of affected children in schools. In 
this systematic review of the global literature, we summarize the reasons caregivers give 
for telling or not telling children 12 and under their HIV diagnosis. We also include articles 
in which children reflect on their desires for being told. While a broad number of reasons 
are given for telling a child – e.g., to aid in prevention, adaptation to illness (e.g., primarily 
to promote treatment adherence), understanding social reactions, and maintaining the 
child–adult relationship – a narrower range of reasons, often related to immediate child or 
caregiver well-being or discomfort, are given for not telling. Recommendations are made 
to improve the context for disclosure by providing supports before, during, and after 
disclosure and to advance the research agenda by broadening samples and refining 
approaches.
Keywords: Hiv, disclosure, stigma, children, global review
iNTRODUCTiON
In countries spread across the globe, mothers, fathers, grandparents, aunts, uncles, sisters, brothers, 
and foster parents must face telling one or more of the children in their care that the children have a 
diagnosis of HIV. Their disclosures often occur against a backdrop of multiple family losses (1–3), and 
in families and communities where not everyone is accepting of those with HIV (4–6). Caregivers 
may face the disclosure process alone, have the assistance of health-care providers, delegate the task 
to providers, or be pre-empted by health systems or inadvertent disclosure (e.g., community gossip, 
visible records, overheard conversations) (7–9). Caregivers face multiple issues during disclosure, 
anticipated by those with experience with children and with global health issues.
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In the opening paragraph of their 1999 recommendations for 
disclosure of HIV/AIDS diagnoses to children, the American 
Academy of Pediatrics (AAP) Committee on Pediatric AIDS 
[(10), p. 164] succinctly states, “Disclosure of HIV infection status 
to children and adolescents should take into consideration their 
age, psychosocial maturity, the complexity of family dynamics, 
and the clinical context.” The World Health Organization [WHO 
(11), p. 12] in its 2011 guidance on disclosure to children 12 
and under provided greater specificity – “children of school age 
should be told their HIV-positive status; younger children should 
be told their status incrementally to accommodate their cognitive 
skills and emotional maturity, in preparation for full disclosure.” 
The guidance also broadened the AAP statement to include the 
community context – schools, institutions, and local and national 
laws and policies. The broader context was deemed important so 
that disclosure could be addressed in a culturally sensitive man-
ner, and so that laws, policies, and institutional or community 
cultures that may be damaging (e.g., lack protections against 
stigmatization of those with HIV) could be changed to foster 
the well-being of HIV+ children and their caregivers (10). Both 
the AAP and WHO documents describe disclosure as a process 
rather than a single event, suggest that HIV+ children’s caregivers 
may need to be supported in the disclosure process, and under-
line the well-being of affected children as a fundamental guide to 
disclosure decision-making.
Several clinicians, researchers, and reviews have suggested 
that knowing their HIV diagnosis in a timely manner enhances 
children’s cooperation with antiretroviral therapy (ART) (11–14), 
helps children understand their illness and promotes self-care 
(15), relieves a burden of secrecy within families (5), prepares 
children to protect others as they approach the teen years which 
often include greater sexual and drug transmission risks (16), 
and, fundamentally, is a right as children mature (4, 8, 17). Risks 
of disclosure to children have also been noted (14), but these 
appear outweighed by benefits (18).
Although progress has been made in reducing HIV preva-
lence among children, especially in preventing mother to child 
transmission during pregnancy, childbirth, and through breast-
feeding, timely disclosure to HIV+ children remains a concern. 
At the end of 2014, an estimated 2.6 million children under age 
15 were living with HIV worldwide, the majority in low and 
middle income countries, an estimated 85% in 21 sub-Saharan 
countries and India. There were approximately 220,000 new 
infections that year; and only an estimated 32% of children 
living with HIV or AIDS were accessing ART, much lower 
than the figures for the adolescent/adult population (10, 19). 
Worldwide a minority of HIV+ children 12 and under (<5%) 
have acquired HIV through blood transfusion, needle sticks, sex 
(sexual abuse, early sexual debut, or sex trafficking), or injected 
drug use (20); the majority acquired HIV through mother to 
child transmission (20).
Researchers and clinicians have worked to translate the 
general guidance for disclosure to children into workable and 
context-sensitive interventions [e.g., Ref. (3, 9, 21–23)]. However, 
in the literature to date, it is most often the primary caregiver, 
with or without assistance from health care workers, who actu-
ally discloses to the HIV+ children in their care. In fact, many 
interventions to aid disclosure, recently developed or under 
development, begin with interviews of caregivers about the issues 
facing them around disclosure. The current review synthesizes 
articles published about caregivers worldwide as they reflect on 
the reasons they have or have not disclosed to HIV+ children. 
In Section “Discussion,” the review is expanded by including 
articles, which summarize the viewpoints of health-care person-
nel and articles summarizing the reflections of HIV+ children 
subsequent to their disclosure experiences. Finally, recommenda-
tions are made for improving research and practice for disclosure 
to children 12 and under.
MeTHODS
Definition of Disclosure
In 1997, Funck-Brentano et al. (24) proposed patterns of disclo-
sure: (1) full disclosure in which HIV is named as the diagnosis, 
(2) partial disclosure in which factual discussions are held about 
symptoms, treatments, and immunodeficiency, and (3) two forms 
of non-disclosure – avoidance/delay and misnaming of the ill-
ness. In our review, we are defining disclosure as full disclosure, 
thus limiting the number of articles eligible for inclusion.
eligibility of Articles
To be included, articles needed to focus on issues regarding dis-
closure of children’s HIV status to HIV+ children 12 and under. 
Articles were included if some, but not all, children met the age 
criteria, i.e., if an article concerned 10–18 year olds. Since ART 
has had a profound effect on the conception of HIV as a treatable 
illness, articles prior to 1996, considered the benchmark year for 
the introduction of ART (21), were excluded. Articles published 
through December 2015 were included. A subset of eligible arti-
cles was entered into a database concerning caregivers’ rationales 
for disclosing or not disclosing. The remaining articles served as 
background material to enhance discussion of the database sum-
mary and of recommendations concerning disclosure research 
and practice.
eligibility for inclusion in a Database of 
Disclosure Rationales
To be included in a database summarizing the reasons caregivers 
gave for fully disclosing or not fully disclosing, the caregivers had 
to be discussing an actual, rather than hypothetical, disclosure 
situation. That is, their descriptions were focused on the child/
children they were caring for and why they had or had not told 
the child his or her HIV status. General discussions about how 
caregivers ought to behave, what respondents thought guided 
caregivers in general, or what caregivers said they might do in 
the future were excluded from the database.
Search
A search of the 60 international databases of the academic arm of 
EBSCO1 was made using the terms (HIV or AIDS), (disclosure or 
telling or diagnosis), and (children or adolescents) from January 
1 https://www.ebscohost.com/academic
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1996 through December 2015. The search was repeated with the 
additional terms (reason or rationale or influenc* or decision or 
factor). Results of the search were checked and expanded by a 
hand search of references in review articles and by a search of 
references in key articles. The current search replicated a search 
conducted by two health librarians, two senior researchers (the 
first and second authors of the current manuscript) and two 
research assistants summarizing literature through June 30, 2010 
for the WHO guidance on disclosure (18). However, the current 
search was limited to disclosure of the child’s own HIV status, 
limited to the post-ART era, and extended to the end of 2015. The 
current search was conducted by the first and third authors and 
checked by the second author through hand search of references 
in key articles and reviews.
Analysis
Abstracts and Method sections were read to ascertain eligibility. 
Full text copies of all eligible articles, save one, were obtained. 
The remaining article was read on-line as full text. Two articles 
were translated into English from Spanish and from Portuguese 
sources; the remaining full texts were in English.
All eligible articles were read in full and then summarized, 
with a subset of articles read by two to three of the authors to 
confirm the accuracy of the summaries. An Excel database was 
created for the 18 articles concerning caregivers’ rationales for 
full disclosure or non-disclosure. It included the source of the 
sample, data sources (e.g., interview, questionnaire), country in 
which the research was conducted, descriptors of the total child 
sample, descriptors of the children told and the caregivers who 
told, rationales for telling and not telling, additional predictors 
of disclosure, and notes about special concerns regarding the 
context or the data. As rationales were accrued, higher order 
categorizations were made, e.g., reasons related to the child’s 
illness, to the parent–child relationship. Categories and higher 
order categories were cataloged in the database. Disagreements 
between the author/analysts were noted and were resolved by 
discussion.
ReSULTS
Search
The full complement of search terms yielded 5,099 articles, 
the vast majority of which were irrelevant, e.g., hearing “aids.” 
Removal of articles focused solely on the clinical picture of HIV/
AIDS in a pediatric population or treatment of pediatric HIV, 
disclosure of parental HIV, disclosure in serodiscordant couples, 
disclosure to family and friends by older youth and adolescents, 
and disclosure for illnesses other than HIV infection also greatly 
reduced the number of articles. Of the remaining 147 articles, 
seven were removed as ineligible (three, although published 
after January 1, 1996, concerned HIV+ children pre-ART; one 
was available only as a conference abstract; one concerned 
HIV+ children above the age range; and one focused solely on 
the prevalence of mental health issues among HIV+ children 
with disclosure mentioned as a potential correlate of adjust-
ment). Hand search of the reference sections of review and key 
articles yielded five additional articles. Thus, the total sample 
consisted of 145 articles pertinent to disclosure to children 
with HIV.
Articles Concerning Caregivers’ Reasons 
for Fully Disclosing or Not Disclosing
Of these 145 articles, 18 (22, 23, 25–40) were selected as meet-
ing inclusion criteria for this review. Listed in Table 1, articles 
concerned (1) caregivers’ rationales for fully disclosing and not 
disclosing children’s HIV status to the children and (2) included 
HIV+ children 12 and under. Five discussed only reasons for 
non-disclosure (22, 29, 31, 37, 40); 3 documented only reasons 
for full disclosure (25, 38, 39); and the remaining 10 covered 
both full disclosure and non-disclosure (23, 26–28, 30, 32–36). 
Data originated from 11 countries: 9 of the 22 United Nations 
priority countries (10) for the elimination of childhood HIV 
[Democratic Republic of the Congo (DRC), Ethiopia, Ghana, 
India, Kenya, Nigeria, South Africa, Uganda, and Zambia], and 
Thailand and the United States of America (USA). Nearly all 
data were collected from urban, regional, or district hospitals 
and clinics or networks of clinics through face-to-face interview, 
or structured, and semi-structured interviews of caregivers, 
with one study collecting sealed confidential surveys (29). Two 
investigators (31, 34) purposively collected rural samples. In 7 
of the 18 articles, HIV+ children or older youth aware of their 
status also provided data (26, 28, 30, 35, 38–40).
Disclosure
Reasons for Full Disclosure
Reasons that caregivers gave for telling their child(ren) are sum-
marized in Table 2. Thirteen articles examined their reasons for 
full disclosure (23, 25–28, 30, 32–36, 38, 39). Since these articles 
varied in whether or not they calculated the frequency with which 
caregivers used these reasons, the reasons are tabulated according 
to the number and percentage of articles in which they appeared 
in tables or text. Heading the list was the “child’s questions or 
curiosity” (mentioned in 69.2% of the articles). This rationale was 
followed by “improve adherence” (61.5%), “child age/maturity” 
(46.2%), “be the one to tell” (46.2%), and “assist child to reduce 
risks to self and others” (46.2%). Seven additional rationales 
were, in order of frequency: “child’s right to know” (38.5% of 
articles), “promote self-care and general health” (38.5%), “keep 
an honest relationship” (30.8%), “explain disease progression 
and/or symptoms” (30.8%), “start medication” (15.4%), “explain 
discrimination” (15.4%), and prepare the child for the disclo-
sure of other’s HIV status, e.g., the status of relatives or friends 
(7.7%). With the exception of the last two rationales, reasons 
were distributed across multiple countries. Thus, the rationales 
appeared to concern maintaining an open parent–child relation-
ship, recognizing the child’s needs and rights, and enlisting the 
child’s cooperation in promoting health and protecting others.
Who Is Told, When, and by Whom
The 13 studies documenting full disclosure together covered 
children in the age range of 4–18 years old. The disclosure rate 
was 31.0% across the 11 (23, 25–28, 31–36) studies for which it 
could be calculated; less than a third of the 1,168 HIV+ children 
TABLe 1 | Characteristics of articles 1996–2015 describing caregivers’ reasons for telling or not telling children in their care the children’s Hiv diagnoses.
Reference Country Sample source Source of data Reasons for 
disclosing  
mentioned
Reasons for 
not disclosing 
mentioned
Abebe and Teferra 
(22)
Ethiopia Pediatric infectious disease clinic 
associated with a hospital
Open- and close-ended questionnaires 
for caregivers
– Yes
Atwiine et al. (23) Uganda Tertiary referral pediatric clinic Structured questionnaire for caregivers 
and medical records of youth
Yes Yes
Bhattacharya et al. 
(25)
India ART clinic of a North Indian  
hospital
Semi-structured questionnaire for 
caregivers and patient records
Yes –
Boon-Yasidhi et al. 
(26)
Thailand Pediatric HIV clinic associated 
with a hospital
Semi-structured interview of caregivers 
and youtha
Yes Yes
Brown et al. (27) Nigeria University hospital Semi-structured questionnaire for 
caregivers
Yes Yes
Fetzer et al. (28) Democratic Republic 
of the Congo
HIV clinic Semi-structured interview with 
caregivers and youtha
Yes Yes
Flanagan-Klygis 
et al. (29)
USA Hospital-based HIV clinic Sealed confidential questionnaire for 
caregivers
– Yes
Kallem  
et al. (30)
Ghana Pediatric HIV clinic Structured questionnaires for caregivers 
and youtha and medical records
Yes Yes
Kiwanuka  
et al. (31)
Uganda Rural regional hospital In-depth interview of caregivers – Yes
Lester et al. (32) USA Children’s and general hospital Questionnaires and interview of caregivers Yes Yes
Mahloko and 
Madiba (33)
South Africa District hospital Interview of caregivers Yes Yes
Mweemba  
et al. (34)
Zambia Two clinics and a hospital in a 
rural area
Case studies and in-depth interview of 
caregivers
Yes Yes
Naidoo and 
McKerrow (35)
South Africa Pediatric ART clinic associated 
with a hospital
Questionnaires administered to 
caregivers and youtha
Yes Yes
Oberdorfer  
et al. (36)
Thailand A university and a district hospital Semi-structured questionnaire for 
caregivers
Yes Yes
Tadesse  
et al. (37)
Ethiopia Hospital-based HIV/AIDS clinic Structured questionnaire for caregivers 
and patient records
– Yes
Vaz  
et al. (38)
Democratic Republic 
of the Congo (DRC)
Three urban care and treatment 
organizations
Interviews of caregivers and youtha Yes –
Vaz  
et al. (39)
Democratic Republic 
of the Congo (DRC)
In-depth interviews of caregivers and 
youtha
Yes –
Vreeman  
et al. (40)
Kenya Eight HIV treatment health  
facilities
Baseline questionnaires of caregivers and 
youth in a disclosure intervention study
– Yes
aIn the indicated articles, youth who already had been told their HIV status were interviewed about the disclosure experience.
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and youth sampled had been told their diagnosis. The rate varied 
from a low of 13.5% in a relatively large Nigerian study (27) to 
a high of 56.7% in a small Zambian study (34).
Calculating across the 12 studies where the mean or median 
age at disclosure was reported or could be calculated (23, 25–27, 
31–36, 38, 39), on average HIV+ children were 10.6 when told 
their diagnosis. Mean age varied from a low of 8.7 to a high of 15.0 
across studies. Many studies did not include measures of range or 
variability, so it is difficult to infer the youngest and oldest ages 
at disclosure.
Caregivers were described with varying degrees of specificity 
(e.g., parent vs. mother or father) study to study. Table 3 suggests 
that a significant minority of caregivers were grandparents and 
other relatives and that health-care personnel had taken on an 
important role in disclosure. Further, at least three studies (32, 
36, 38) documented that children may learn about their HIV 
status inadvertently or by inference (e.g., looking at their medical 
records, overhearing discussions, or inferring from HIV public 
service announcements or talk among school friends).
Reasons for Not Disclosing
Table 4 summarizes the reasons that caregivers gave for not tell-
ing their child(ren). Fifteen articles (22, 23, 26–37, 40) discussed 
these reasons. The most prevalent reasons were “anticipation of 
the child’s negative psychological reaction” (mentioned in 93.3% 
of the articles). This rationale was followed by “the child is too 
young to understand” (86.7%), “the child is unable to keep a 
secret” (66.7%), “potential social rejection of the child” (60.0%), 
and “the parent fears anger/blame from the child” (53.3%). Five 
additional rationales were, in order of frequency: “caregiver feels 
he/she lacks the skills to communicate HIV status to the child” 
(40.0% of articles), “parent fears shame/guilt” (20.0%), “parent 
TABLe 2 | Number of articles citing the specific reasons caregivers offer 
for disclosing a child’s Hiv status to the child.
Rationale for 
telling a child  
his or her 
Hiv status
Number (%) of 
articles in which 
mentioned  
(N = 13)
Countries 
represented
Reference
Maintain the caregiver–child and other relationships
Be the one  
to tell
6 (46.2) Uganda Atwiine et al. (23)
Thailand Boon-Yasidhi et al. (26)
India Bhattacharya et al. (25)
S. Africa Mahloko and 
Madiba (33)
Zambia Mweemba et al. (34)
DRC Vaz et al. (38)
Keep an honest 
relationship
4 (30.8) Thailand Boon-Yasidhi et al. (26)
USA Lester et al. (32)
Zambia Mweemba et al. (34)
DRC Vaz et al. (38)
Prepare child for 
disclosure of  
others’ HIV
1 (7.7) USA Lester et al. (32)
Child-related reasons
Child’s  
questioning/
curiosity
9 (69.2) Uganda Atwiine et al. (23)
Thailand Boon-Yasidhi et al. (26)
Nigeria Brown et al. (27)
Ghana Kallem et al. (30)
USA Lester et al. (32)
S. Africa Mahloko and 
Madiba (33)
Zambia Mweemba et al. (34)
S. Africa Naidoo and 
McKerrow (35)
DRC Vaz et al. (38)
Child’s  
age/maturity
6 (46.2) Uganda Atwiine et al. (23)
Thailand Boon-Yasidhi et al. (26)
Nigeria Brown et al. (27)
Ghana Kallem et al. (30)
S. Africa Mahloko and 
Madiba (33)
DRC Vaz et al. (38)
Child’s right  
to know
5 (38.5) Uganda Atwiine et al. (23)
Thailand Boon-Yasidhi et al. (26)
Nigeria Brown et al. (27)
USA Lester et al. (32)
S. Africa Naidoo and 
McKerrow (35)
Social
Explain 
discrimination/
stigmatization
2 (15.4) Thailand Boon-Yasidhi et al. (26)
Thailand Oberdorfer et al. (36)
Prevention
Reduce risks  
to self and  
others
6 (46.2) Uganda Atwiine et al. (23)
Thailand Boon-Yasidhi et al. (26)
USA Lester et al. (32)
S. Africa Mahloko and 
Madiba (33)
DRC Vaz et al. (38)
DRC Vaz et al. (39)
illness-related explanations and events
Improve  
adherence
8 (61.5) Uganda Atwiine et al. (23)
Nigeria Brown et al. (27)
DRC Fetzer et al. (28)
USA Lester et al. (32)
Rationale for 
telling a child  
his or her 
Hiv status
Number (%) of 
articles in which 
mentioned  
(N = 13)
Countries 
represented
Reference
S. Africa Mahloko and 
Madiba (33)
Zambia Mweemba et al. (34)
DRC Vaz et al. (38)
DRC Vaz et al. (39)
Promote  
self-care and 
general health
5 (38.5) Nigeria Brown et al. (27)
India Bhattacharya et al. (25)
Ghana Kallem et al. (30)
USA Lester et al. (32)
DRC Vaz et al. (38)
Disease 
progression/
symptoms
4 (30.8) Uganda Atwiine et al. (23)
S. Africa Mahloko and 
Madiba (33)
Thailand Oberdorfer et al. (36)
DRC Vaz et al. (38)
Start  
medication
2 (15.4) Thailand Oberdorfer et al. (36)
DRC Vaz et al. (39)
TABLe 2 | Continued
(Continued)
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fears rejection by the child” (20.0%), “parent fears child may 
reject drugs” (20.0%), and “parent fears questions from the child” 
(13.3%). The rationales appear to concern potential sociopsycho-
logical harm to the child or the family with only one rationale 
focused on managing the illness.
Correlates of Full Disclosure
It should be noted that for studies that assessed correlates/
predictors of full disclosure rarely did the fact that the child was 
male or female or parent characteristics have an influence. More 
frequently, significant correlates were related to the child’s illness 
and health. These included non-perinatal mode of transmission 
(25); the relative health of the child (feeling well, having hospi-
talizations, having new symptoms or suddenly worsening health) 
(35, 36, 40); other health transitions (e.g., starting ART) (25, 33, 
40); and experience managing the illness (e.g., longer duration 
of illness, longer time on ART, self-administration of medicines) 
(25, 30). Child social and intellectual factors included life transi-
tions (e.g., enrolling in school) (25, 33), and signs of cognitive 
maturity (being in school, being more educated, higher IQ) (30, 
32, 33). For caregivers, both higher (25) and lower education 
(35) have been associated with disclosure. Disclosure of either 
the caregiver’s HIV status to the child or the child’s HIV status 
to other family members (23, 37) have been cited as promoting 
disclosure. Family communication factors have also been signifi-
cantly associated with disclosure: children’s persistence in asking 
questions about their illness (33) and a family environment that 
encourages the direct expression of feelings (32). Only the pres-
ence of the biological father seems to be associated with lower 
disclosure (30, 33, 36).
DiSCUSSiON
Eighteen articles, January 1996 through December 2015, cata-
loged caregiver’s rationales for fully disclosing or not disclosing 
TABLe 3 | How many are told, at what age, and by whom.
Reference Total  
child N
Age range of  
total sample
Mean age (SD) 
of total sample
N (%) of  
sample told
Age range 
when told
Mean age (SD) 
when told
who told N (%)b
Atwiine et al. (23) 307 5–17 Median 8 95 (30.9) – 11.6 (–) Mother 47 (50.0)
Other relative 28 (29.8)
Father 10 (10.6)
Grandparent 9 (9.6)
Bhattacharya  
et al. (25)
145 ≥5 9.1 (–) 60 (41.4) ≥5 9.1 (1.4) Parents 51 (85.0)
Other relative 6 (10.0)
Health care 3 (5.0)
Staff
Boon-Yasidhi  
et al. (26)
96 5–15 8.6 (–) 19 (20.0) – 9.6 (–) Mother 7 (36.8)
Step-parent 5 (26.3)
Father 3 (15.8)
Grandparent 3 (15.8)
Sister 1 (5.3)
Brown et al. (27) 96 6–14 8.8 (2.2) 13 (13.5) 4.5–13 8.7 (2.2) Mother 6 (46.1)
Father 3 (23.1)
Stepmother 1 (7.7)
Aunt 1 (7.7)
Grandfather 1 (7.7)
Health care 1 (7.7)
Worker
Fetzer et al. (28) 20 9–17 – 4 (20.0) – – Caregiver 3 (75.0)
Other 1 (25.0)
Kallem et al. (30) 71 8–14 10.4 (1.7) 15 (21.1) – 11.7 (1.9) Caregivers 15 (100.0)
Lester et al. (32) 51 6–10 8.3 (–) 22 (43.1) – Median 9.7 Caregivers 16 (72.7)
Child knew 3 (13.6)
Inadvertent 2 (9.1)
Health care 1 (4.5)
Worker
Mahloko and 
Madiba (33)
149 4–17 8.2 (3.1) 59 (39.6) 4–17 9.3 (2.9) Mother 23 (39.7)
Grandparent 17 (29.3)
Health care 13 (22.4)
Worker
Other relative 5 (8.6)
Mweemba et al. (34) 30 10–15 11.9 (–) 17 (56.7) 10–15 12.2 (–) –
Naidoo and 
McKerrow (35)
100 8–14 10.9 (–) 27 (27.0) – 11.6 (0.3) Parent 23 (84.6)
Grandparent 3 (11.5)
Nurse 1 (3.9)
Oberdorfer et al. (36) 103 6–16 9.5 (–) 31 (30.1) 4–15 9.2 (3.0) Grandparent 10 (32.2)
Health care 9 (29.0)
Provider
Mother 5 (16.1)
School friends 5 (16.1)
Other relative 2 (6.4)
Vaz et al. (38)a 19 10–18 15.0 (–) Health care 11 (52.4)
Worker
Parent 9 (42.9)
Inadvertent 1 (14.3)
Vaz et al. (39)a 8 8–16.5 12.6 (–) Mother 5 (71.4)
Father 1 (14.3)
Health care 1 (14.3)
Worker
aVaz et al. (38, 39) studied only HIV+ youth who had been disclosed to; thus, the proportion who experienced disclosure could not be calculated.
bIn some cases, the number of caregivers is greater than the number of children told, because the youth were told jointly by multiple caregivers; in others, the number of caregivers is 
less because multiple children were told.
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children’s HIV status to children 12 and under post-ART. The 
studies covered an age range for children from 4 to 18, and across 
11 countries, including 9 targeted by the United Nations for the 
elimination of childhood HIV, documented an average rate of 
disclosure of 31%. On average, HIV+ children who were told 
were over 10, well beyond the recommendation to tell school-age 
TABLe 4 | Number of articles citing the specific reasons caregivers offer 
for not disclosing a child’s Hiv status to the child.
Rationale for  
not telling a  
child his or  
her Hiv  
status
Number (%) of 
articles in which 
mentioned  
(N = 15)
Countries 
represented
Reference
Parent–child relationship reasons
Fears  
anger/blame  
from child
8 (53.3) Uganda Atwiine et al. (23)
Thailand Boon-Yasidhi et al. (26)
Nigeria Brown et al. (27)
Uganda Kiwanuka et al. (31)
USA Lester et al. (32)
S. Africa Mahloko and Madiba 
(33)
Zambia Mweemba et al. (34)
S. Africa Naidoo and McKerrow 
(35)
Fears rejection 
by child
3 (20.0) Thailand Boon-Yasidhi et al. (26)
USA Lester et al. (32)
Uganda Kiwanuka et al. (31)
Fears  
questions 
from child
2 (13.3) USA Flanagan-Klygis et al. 
(29)
S. Africa Mahloko and Madiba 
(33)
Child-related reasons
Anticipates  
negative 
psychological 
reaction by  
child
14 (93.3) Ethiopia Abebe and Teferra (22)
Uganda Atwiine et al. (23)
Thailand Boon-Yasidhi et al. (26)
Nigeria Brown et al. (27)
USA Flanagan-Klygis et al. 
(29)
Ghana Kallem et al. (30)
Uganda Kiwanuka et al. (31)
USA Lester et al. (32)
S. Africa Mahloko and Madiba 
(33)
Zambia Mweemba et al. (34)
S. Africa Naidoo and McKerrow 
(35)
Thailand Oberdorfer et al. (36)
Ethiopia Tadesse et al. (37)
Kenya Vreeman et al. (40)
Too young to 
understand
13 (86.7) Ethiopia Abebe and Teferra (22)
Uganda Atwiine et al. (23)
Thailand Boon-Yasidhi et al. (26)
Nigeria Brown et al. (27)
USA Flanagan-Klygis et al. 
(29)
Ghana Kallem et al. (30)
USA Lester et al. (32)
S. Africa Mahloko and Madiba 
(33)
Zambia Mweemba et al. (34)
S. Africa Naidoo and McKerrow 
(35)
Thailand Oberdorfer et al. (36)
Ethiopia Tadesse et al. (37)
Kenya Vreeman et al. (40)
Child unable to 
keep a secret
10 (66.7) Ethiopia Abebe and Teferra (22)
Uganda Atwiine et al. (23)
Thailand Boon-Yasidhi et al. (26)
Nigeria Brown et al. (27)
Rationale for  
not telling a  
child his or  
her Hiv  
status
Number (%) of 
articles in which 
mentioned  
(N = 15)
Countries 
represented
Reference
USA Flanagan-Klygis et al. 
(29)
Ghana Kallem et al. (30)
USA Lester et al. (32)
S. Africa Mahloko and Madiba 
(33)
Thailand Oberdorfer et al. (36)
Ethiopia Tadesse et al. (37)
Potential  
social rejection  
of child
9 (60.0) DRC Fetzer et al. (28)
USA Flanagan-Klygis et al. 
(29)
Uganda Kiwanuka et al. (31)
USA Lester et al. (32)
S. Africa Mahloko and Madiba 
(33)
Zambia Mweemba et al. (34)
S. Africa Naidoo and McKerrow 
(35)
Thailand Oberdorfer et al. (36)
Kenya Vreeman et al. (40)
Caregiver-related reasons
Caregiver feels  
he/she lacks 
the skills to 
communicate  
HIV status to 
the child
6 (40.0) Uganda Atwiine et al. (23)
Thailand Boon-Yasidhi et al. (26)
Uganda Kiwanuka et al. (31)
S. Africa Mahloko and Madiba 
(33)
Zambia Mweemba et al. (34)
S. Africa Naidoo and McKerrow 
(35)
Parent fears 
shame/guilt
3 (20.0) Uganda Atwiine et al. (23)
Thailand Boon-Yasidhi et al. (26)
Zambia Mweemba et al. (34)
illness-related reasons
Fears child  
may reject | 
drugs
3 (20.0) Nigeria Brown et al. (27)
S. Africa Naidoo and McKerrow 
(35)
Ethiopia Tadesse et al. (37)
(Continued)
TABLe 4 | Continued
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children (primary school starting ages are typically 5–7 world-
wide according to World Bank Data2) or the age of assent, 7 years 
old, for children in clinical trials (18, 41, 42). Indeed some studies 
did not include children in lower age ranges [e.g., Ref. (32, 39)] 
restricting the range for mean age of disclosure. A few children 
learned their HIV status inadvertently; a significant minority was 
told by grandparents, other relatives or by health-care providers; 
an apparent majority were told by biological parents.
Although data were gathered principally from urban treat-
ment centers, 69% of the more than 1,100 children and youth in 
these studies had not learned their HIV status.
Across articles, caregivers cited reasons for disclosing that 
emphasized the child’s needs (the child’s questions or curiosity, 
2 http://data.worldbank.org/indicator/SE.PRM.AGES
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child’s age/maturity, child’s right to know, explain discrimina-
tion), maintenance of an open caregiver–child relationship (be 
the one to tell, keep an honest relationship, prepare the child 
for the disclosure of others’ HIV), and enlisted the child’s 
cooperation in promoting health and protecting others (improve 
adherence, assist child to reduce risks to self and others, promote 
self-care and general health, explain disease progression and/or 
symptoms, start medication) (23, 25–28, 30, 32–36, 38, 39). In 
addition, external events, such as enrollment in school (25, 33) 
or admission to the hospital (35, 36, 40), were cited as motivating 
disclosure.
Reasons for not disclosing concerned fears about potential 
sociopsychological harm to the child (anticipation of the child’s 
negative psychological reaction, child is too young to understand, 
potential social rejection of the child) or to the family (child is 
unable to keep a secret, parent fears anger/blame from the child, 
caregiver feels he/she lacks the skills to communicate HIV status 
to the child, parent fears shame/guilt, parent fears rejection by 
the child, parent/caregiver fears questions from the child) (22, 
23, 26–37, 40) with one rationale focused on managing the illness 
(caregiver fears child may reject drugs) (27).
Some of these fears have merit as documented by a number of 
studies. Children’s initial reactions of sadness, worry, confusion, 
and shock have been described (36, 39, 43), as have instances 
of discrimination and bullying at school and in communities 
(1, 8, 44). Caregivers and even health-care providers may lack 
the knowledge and skills to effectively communicate an HIV 
diagnosis to the child (45), and some of this may be due to HIV+ 
caregivers’ own negative disclosure experiences (3).
However, an even broader literature indicates that children’s 
initial reactions dissipate relatively quickly over time (43, 46) and 
may be overestimated by caregivers, especially caregivers who 
themselves have issues of anxiety or depression (35, 47). At least 
one study, interviewing children, reported that disclosure was 
not associated with more negative psychological outcomes (40). 
Knowing one’s HIV status does appear to be associated with stable 
or improved child well-being (18, 48) and disease management 
(11–13). Children, themselves, reflecting on disclosure often 
mention a sense of relief, wishing that disclosure had happened 
earlier, that their questions had been answered more directly and 
that more support had been available initially and subsequently 
in the family, community, and health-care setting (33, 39, 45, 49, 
50). In some studies, children also described their own improved 
adherence (28, 40).
Regarding discrimination, the literature seems to suggest 
intervention at the local, institutional, and national policy level. 
It is not only children with HIV who experience teasing and bul-
lying – often especially upsetting to children because of pervasive 
messages about sexual transmission – but those presumed to have 
HIV because of a rash, an illness, a family illness, slight stature, or 
geographic location of high HIV prevalence, whether indeed they 
have HIV or not (1, 6, 44).
Research Recommendations
Include a Broader Set of Populations
In the search for articles worldwide that focused on car-
egiver  reasons for disclosure to children, only 9 of the 22 high 
priority countries for the elimination of childhood HIV were 
represented  (10). Missing from the 18 articles found were the 
remaining 13 countries: Angola, Botswana, Burundi, Cameroon, 
Chad, Cote d’Ivoire, Lesotho, Malawi, Mozambique, Namibia, 
Swaziland, United Republic of Tanzania, and Zimbabwe. Thus, 
we do not know if the limited set of rationales, documented here 
and relatively stable across the countries studied, would also hold 
for the remaining highly affected countries.
Samples were almost always drawn from urban treatment 
centers. Many excluded orphans or children at boarding schools. 
Almost all focused exclusively on perinatally infected children 
and youth. Thus, our picture of disclosure to children would be 
enhanced by looking at rural, out-of-treatment, orphaned, board-
ing school, and non-perinatally infected children as well (22, 31, 
51). Some research programs in progress have made steps in that 
direction (25, 27, 34, 45, 52); some have conducted research at 
community sites overcoming biases toward studying only treated 
populations and overcoming barriers to participation in research 
such as travel to health center research sites [e.g., Ref. (22)].
Gather Data in a Way That Enhances Systematic 
Review or Cross-Study Comparisons
Data standards, such as CONSORT,3 recommend collection of 
summary statistics and their precision. That is, statistics ought 
be reported with accompanying measures of variability; many 
times, mean age at disclosure was reported without a measure of 
variability such as the SD; sometimes only frequencies of varying 
age ranges were reported (e.g., ages 5–9, 10–12, etc.) from which 
the current authors may or may not have been able to calculate 
a summary measure such as the median. Standards were often 
not met regardless of qualitative, quantitative, or mixed-method 
approaches.
Improve Description with More Precise Measures
Articles differed in the precision with which variables were 
described, e.g., some articles excluded from the current sum-
mary did not specify whether the age of the child at the time of 
disclosure or age at time of interview about disclosure were being 
discussed. In describing who disclosed, some articles indicated 
“caregivers” or “health-care personnel,” while others specified the 
precise relationship of the discloser to the child (e.g., grandfather) 
or the exact role of the health-care provider (e.g., nurse, infectious 
disease doctor). Some indicated who was present when a number 
of individuals participated in disclosing (e.g., multiple people, 
suggesting some caregivers rely on the simultaneous support of 
health-care providers and other family members). The greater the 
precision, the easier it is to make cross-study comparisons and 
summaries. Further, the literature indicates that health personnel 
in differing roles may have differing attitudes (34, 53) and that 
caregivers in differing relationships may have differing issues 
about HIV disclosure (3, 15). Doctors appear to be greater advo-
cates of early disclosure; HIV+ parents and grandparents may be 
involved in disclosing their own and relatives’ HIV along with the 
HIV status of the child (4).
3 http://www.consort-statement.org/
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No article asked the caregivers to reflect in a systematic way 
(e.g., Likert scales, paired comparison) on what experiences or 
what rationales were most influential in making the disclosure 
decision. Only one article (29) tried to eliminate the social desir-
ability reporting bias that comes with face-to-face interviews or 
questionnaires handed directly to study personnel. New tech-
niques, used with low literacy populations, may help reduce such 
biases by using voice recordings of questionnaires/interviews 
with study personnel available for assistance.
Improve Prediction with Longitudinal Data  
and Child Well-being Outcome Measures
By definition, the articles summarized here dealt with reflection 
on past behavior and thus were subject to biases of memory. Most 
studies relied on caregivers’ recall about date of disclosure, child 
reactions, and who may have been present. In fact, sometimes 
HIV+ children’s and caregivers’ accounts did not agree (14, 26, 
35). Further, although a rationale may be thought to be influ-
ential, until research occurs pre- to post-disclosure, its influence 
cannot be verified. For example, Jemmott et al. (54), in research 
on intention to disclose found multiple reasons endorsed, but 
only normative beliefs – the perception that friends, relatives, 
and others important to the caregiver would want them to tell 
the child – and self-efficacy – belief they can tell the child – were 
significant predictors in a multiple regression of the intention to 
disclose. Further, it is as yet unknown, whether “telling” under 
certain circumstances or for certain reasons is more or less ben-
eficial for the HIV+ child in physical and mental health domains 
and in social adjustment.
Longitudinal analysis about illnesses can be exacting (48): over 
time individuals get better with treatment or decline, older age 
brings new challenges such as older youth being more involved 
in maintaining their own treatment, caregiver–child relation-
ships change with time, health-care settings, and personnel 
change with time. Disclosure unfolds alongside these processes. 
Documentation over time would inform interventions that could 
meet time- and maturation-dependent challenges.
Transition to Evaluation of Interventions
As suggested by multiple authors (14, 18, 27, 30), the research 
question no longer seems to be whether or not to fully disclose 
to children, but when and how. Several promising interventions 
have been designed or piloted (9, 15, 55, 56), with their com-
mon elements described below under clinical recommendations. 
Nearly all carry with them advice to be age- and context-sensitive.
Measure and Report Context at the Individual, 
Family, Community, Institutional, and National Levels
In largely quantitative articles, however, context is rarely described 
beyond a few characteristics of the affected children, their 
caregivers, several attributes of the family situation (e.g., child 
being raised by relatives, or an HIV+ parent) or where disclosure 
took place (e.g., home or clinic setting). The articles, providing 
background for this review, that do describe context – sometimes 
in case studies, policy papers or research on allied topics such as 
adherence – are compelling. A few examples will suffice: dilem-
mas faced by a grandmother who had promised her deceased 
daughter to never reveal the daughter had died of AIDS, but now 
discovers the grandchild she is raising is HIV+ (57); disclosure 
occasioned in a rural district by the child having to travel alone 
to get care (34); the differing issues for child-headed households 
in post-genocide Rwanda (8); marginalized and at-risk child and 
youth populations in India such as street children and children 
pressed into sex trade (51); secrecy and collusion about illness 
and medicine-taking within families in a community with high 
stigmatization of HIV (5); cultural conflict when fathers are family 
decision-makers, but mothers manage health care and are being 
told to disclose (15); and the surprise an HIV+ child felt when 
told her HIV+ status by an apparently healthy HIV+ adult nurse 
because of the child’s assumptions about how HIV progresses 
(58). Again some research programs are beginning to assess not 
only caregiver and health-provider attitudes but attitudes and 
policies of surrounding communities and institutions such as 
health-care clinics, hospitals, churches, and schools (1, 7, 8, 52,   
54, 59), leading to additional targets for intervention. Systematic 
reporting about issues at multiple levels will aid context-sensitive 
full disclosure.
Improve Understanding with Mixed  
Qualitative–Quantitative Research
Several studies summarized here reported comments by older 
children, caregivers, and health-care providers reflecting on 
disclosure experiences. Such qualitative data were illuminating. 
For example, several disclosures were initiated because children 
did not understand why they had to keep taking medicines if their 
symptoms had disappeared (28, 34). Importantly, some researches 
documented that children who had not been told, already knew or 
suspected their diagnosis (35), or children who supposedly knew 
had not understood the disclosure fully (26, 40). Children in one 
study reported having questions post-disclosure while caregivers 
were unaware of their questions (39). Qualitative data, especially 
from the viewpoint of the children whose well-being is being 
fostered, can anticipate and correct likely misunderstandings.
In additional research (50, 60), older youth also indicated 
where they received valuable support for coping with HIV, 
described more fully below (see Expand Training before Full 
Disclosure).
Clinical Recommendations
Abrupt, delayed, or inadvertent disclosure has been described 
as harmful (15), while full disclosure has been cited as helpful 
to HIV+ children (18). As described in Sections “Common 
Elements in Interventions for Full Disclosure,” “Expand Training 
before Full Disclosure,” “Expand Support during Full Disclosure,” 
and “Expand Support after Full Disclosure” interventions are 
being developed to assist caregivers and children before, during, 
and after full disclosure so that the potential health benefits of 
full disclosure can be realized, and potential negative effects 
anticipated and ameliorated.
Recommended Age for Disclosure
While caregivers’ attitudes and beliefs about the best age for 
disclosure vary widely, systematic guidelines recommend 
age-appropriate disclosure to school-age children (18). While 
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caregivers hold understandable concerns about potential nega-
tive consequences for children of early school age, objective infor-
mation about children’s short-term reactions such as shock and 
fear and about long-term benefits such as improved adherence 
to health regimens may mitigate these worries and provide the 
impetus for full disclosure. Health-care providers also may often 
be unaware of best practices in terms of child age; for example, 
they may lack knowledge of how to use age-appropriate language 
during full disclosure (9, 15, 55, 56).
Common Elements in Interventions for Full 
Disclosure
Several systematic disclosure interventions have been designed 
or piloted (9, 15, 55, 56). They have the following common ele-
ments: (1) train health-care providers to assist with disclosure, 
(2) elicit caregiver concerns regarding disclosure, (3) assess child 
and caregiver readiness for full disclosure, (4) improve readiness 
by addressing concerns and rehearsing communications to child, 
(5) disclose with requested assistance, and (6) follow-up with 
assessment. Generally, the interventions take place in a health-
care setting.
Expand Training before Full Disclosure
Several articles have suggested the need for training before full 
disclosure for health personnel, for parents/caregivers, and 
for children (22, 23, 26–31, 33–35, 37–39). Commonly, pre-
disclosure interventions suggest responding to triggers such as 
questions from the child in honest, age-appropriate ways: for 
example, explaining about germs and medicines with drawings, 
and analogies such as the body protecting itself with little soldiers 
and medicines to help the soldiers (56, 58). Suggestions for health 
personnel include the use of simple language – terms such as 
“positive” have a vernacular meaning – and educating caregivers 
about HIV (57).
However, it also seems to be the case that garnering the com-
munity support that will ultimately be needed ought to begin prior 
to full disclosure [e.g., Ref. (32)]. HIV+ children, ages 10–14, 
reflecting on their disclosure experiences, commented that safe 
persons (relatives and friends who knew and understood) and 
safe places (e.g., a church group) were particularly helpful to 
them in their adjustment to living with HIV after learning their 
diagnosis (50). But schools have often been described as not safe. 
At least one article suggests that few families disclose to school 
personnel but may need special school services for their HIV+ 
children (61). It seems reasonable that educative efforts should 
be extended to these ultimate sources of support, especially since 
the majority of children in the articles summarized here are in 
school, some in boarding school separated from family supports 
(22, 25, 27, 30, 33, 37).
Expand Support during Full Disclosure
Blasini et al. (55), in early work, stressed the importance of letting 
caregivers decide whether they wanted to disclose alone or with 
the assistance of health-care providers. Preferences in the articles 
summarized here seem to vary country to country and person 
to person, with some caregivers wishing to disclose alone, or 
with other relatives present, or with assistance from health-care 
providers, or with another complement of individuals (22, 30, 
35). Some caregivers wished to defer and let health-care providers 
disclose directly to the child (7). Sometimes the caregiver deci-
sion was co-opted by the health-care system; disclosure occurred 
without caregiver input [e.g., Ref. (41, 43)]. In some cases, 
caregivers were actively discouraged from disclosing by health-
care personnel (23, 34). Neither article explicated the health-care 
worker’s reasons for being discouraging, but one documented 
the caregivers’ strong perception of health personnel’s negative 
attitudes toward disclosure (34).
Older HIV+ youth reflecting on their earlier disclosure experi-
ences may be an important source of decision-making. In at least 
one study (62), health-care workers encouraged disclosing alone 
at home, while youth preferred disclosure with health personnel 
and the caregiver in a health setting. Youth also often complained 
that their questions were not heard or answered; communication 
was directed to adults rather than to them (39). These two stud-
ies concern youth who had been told when they were older than 
early school age. It is likely that preferences might vary by context 
and child maturity.
Consensus guidelines on breaking bad news in the field of can-
cer suggest that disclosure should take place across several meet-
ings including enough time to assess the patient’s understanding 
and emotional status, encourage expression of feelings and 
respond empathetically, arrange a time to review the situation, 
offer assistance telling others, and provide information about 
support services as well as discussing treatment (63, 64). Yet, 
some caregivers in the studies reviewed here believed disclosure 
should be a discreet event (31).
Expand Support after Full Disclosure
Several articles recommended continuing supports for both 
caregivers and children post-disclosure (13, 22, 28, 31). Peer 
groups would assist both caregivers and children to adjust to 
HIV post-disclosure as would continuing education about HIV 
and its treatment. Caregivers may need support concerning car-
egiver–child communication, including appropriate language to 
use with children, how to explore local cultural factors influ-
encing adjustment to illness, and how to deal with caregiver or 
child fears about the consequences of disclosure (16). Children 
may need resources to deal with stigmatizing experiences, to 
support their physical and mental health, and to aid their access 
to health care.
Concluding Statement
The emphasis on whether or not to disclose an HIV diagnosis to 
children, driving research since the early 1990s, has now shifted 
to when and how children should be told. Recent evidence sug-
gests that caregivers may want to tell an HIV+ child that the child 
has HIV, but may fear negative consequences for their families 
and children. To alleviate their concerns, more support may be 
necessary prior to, during, and after disclosure. The nature of this 
support should include the voices of older HIV+ youth aware 
of their diagnoses, caregivers, health-care providers, and those 
knowledgeable about local context. To address stigma, support 
may require changes in institutional policies to address stigma-
tizing behaviors, encourage physical/mental health, and foster 
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social acceptance in the communities where HIV+ children 
live. To promote child well-being across the local, institutional, 
and national contexts that HIV+ children face, future research 
should aim toward developing “best practice” child-sensitive and 
context-sensitive standards of HIV disclosure for caregivers and 
health-care providers.
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